Development of Clinical Database of Individuals With Smith-Magenis Syndrome
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Maximum Age: 65
Healthy Volunteers: f
View:
• Parent or legal guardian of individual with Smith-Magenis Syndrome
Locations
United States
Washington, D.c.
Vanda Pharmaceuticals
RECRUITING
Washington D.c.
Contact Information
Primary
Vanda Pharmaceuticals
clinicaltrials@vandapharma.com
202-734-3400
Time Frame
Start Date: 2016-01
Estimated Completion Date: 2030-12
Participants
Target number of participants: 1000
Related Therapeutic Areas
Sponsors
Leads: Vanda Pharmaceuticals